Evidence map›Paper›PMID 35207339›Full record

ArticleJournal of clinical medicine2022

Feasibility Trial to Evaluate Tendon Stiffness Obtained from Shear Wave Elastography Imaging as a Biomarker of Aromatase Inhibitor-Induced Arthralgias.

Jessica A Martinez, Mihra S Taljanovic, Andres A Nuncio Zuniga, Betsy C Wertheim, Denise J Roe, Sima Ehsani, Sao Jiralerspong, Jennifer Segar, Pavani Chalasani

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of clinical medicine, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.9field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

Jessica A MartinezThe University of Arizona Cancer Center, Tucson, AZ 85719, USA.ORCID 0000-0001-5811-1019
Mihra S TaljanovicDepartment of Medical Imaging and Orthopaedic Surgery, University of Arizona, Tucson, AZ 85719, USA.
Andres A Nuncio ZunigaDepartment of Biomedical Engineering, University of Arizona, Tucson, AZ 85719, USA.
Betsy C WertheimThe University of Arizona Cancer Center, Tucson, AZ 85719, USA.
Denise J RoeThe University of Arizona Cancer Center, Tucson, AZ 85719, USA.
Sima EhsaniThe University of Arizona Cancer Center, Tucson, AZ 85719, USA.
Sao JiralerspongThe University of Arizona Cancer Center, Tucson, AZ 85719, USA.
Jennifer SegarThe University of Arizona Cancer Center, Tucson, AZ 85719, USA.ORCID 0000-0002-6345-2093
Pavani ChalasaniThe University of Arizona Cancer Center, Tucson, AZ 85719, USA.
University of Arizona · US

Funding

University of Arizona Cancer Center (internal funding) CROC
6 · The paper itself

Abstract

Aromatase inhibitor-induced arthralgia (AIA) comprises significant, activity-limiting musculoskeletal symptoms, including joint pain, myalgia, and joint stiffness. We conducted a prospective feasibility study in postmenopausal women diagnosed with early-stage (0-3) hormone receptor positive (HR+) breast cancer who were candidates for treatment with adjuvant AI therapy (

Indexed as

aromatase inhibitor–induced arthralgia (AIA)aromatase inhibitorsarthralgiabreast cancerjoint painshear wave elastographystiffnessultrasound

Identifiers

PMID35207339
PMCPMC8875194
OpenAlexW4214719326

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.